# LifeForce Capital

LifeForce Capital is a Private Equity based in Chevy Chase, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Chevy Chase, United States
- **Region:** North America
- **Address:** Chevy Chase, MD, United States
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** lifeforcecap.com

## Regulatory record

- **CRD number:** 282550
- **SEC file number:** 802-118500
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/282550

## About

Lifeforce Capital invests in software companies reshaping the status quo in healthcare’s largest markets. Its companies advance care delivery through new technologies and care models, and drive a paradigm shift away from traditional biotechnology with software-first techbio platforms.

## Sectors

- Digital Health
- Biotechnology
- Healthcare Services
- Enterprise Software

## People

- Michael Galbo — Managing Partner & Portfolio Manager

## Questions

### What is LifeForce Capital's investment strategy?

LifeForce runs a concentrated, long-biased public-equity strategy focused exclusively on healthcare — spanning biotechnology, life sciences tools, diagnostics, and healthcare technology. The firm targets small- to mid-cap companies where it can take meaningful ownership stakes and engage constructively with management teams around capital allocation, pipeline strategy, and operational execution.

### Which sectors does LifeForce Capital avoid?

LifeForce stays entirely within healthcare, avoiding sectors outside its circle of competence — including energy, financials, consumer goods, and general technology. Within healthcare, the firm historically avoids large-cap pharmaceuticals with entrenched pipelines and payer-facing service companies where pricing power is constrained by government reimbursement.

### What is LifeForce's posture on activist engagement?

Galbo pursues constructive engagement rather than hostile activism. The firm takes concentrated positions and uses its stake to discuss capital allocation, pipeline prioritization, and operational milestones with management and boards. It has not waged proxy fights or publicly agitated for C-suite turnover in any disclosed campaign.

## Related profiles

- [Life Extension Ventures](https://altss.com/profile/life-extension-ventures)
- [Life is Too Short Capital](https://altss.com/profile/life-is-too-short-capital)

---

Last updated: 2026-08-11T15:07:19.634Z

Canonical page: https://altss.com/profile/lifeforce-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology